Massmutual Trust CO Fsb Cue Biopharma, Inc. Transaction History

Massmutual Trust CO Fsb

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$2.49 - $5.92 $6,073 - $14,438	-2,439 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$4.41 - $12.28 $2,800 - $7,797	635 Added 35.2%	2,439 $12,000
Q4 2021 Feb 09, 2022	BUY	$10.86 - $17.85 $11,131 - $18,296	1,025 Added 131.58%	1,804 $20,000
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $8,491 - $11,318	779 New	779 $9,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.